Cas:167218-39-5 N,N-Bis(4′-diphenylamino-4-biphenylyl)amine manufacturer & supplier

Chemical Name:N,N-Bis(4′-diphenylamino-4-biphenylyl)amine

CAS.NO:167218-39-5

Synonyms:N,N-Bis(4′-diphenylamino-4-biphenylyl)amine

Molecular Formula:C₄₈H₃₇N₃

Molecular Weight:655.82748

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N,N-Bis(4′-diphenylamino-4-biphenylyl)amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N-Bis(4′-diphenylamino-4-biphenylyl)amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N-Bis(4′-diphenylamino-4-biphenylyl)amine Use and application,N,N-Bis(4′-diphenylamino-4-biphenylyl)amine technical grade,usp/ep/jp grade.

Related News: If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said. N,N-Bis(4′-diphenylamino-4-biphenylyl)amine manufacturer Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. N,N-Bis(4′-diphenylamino-4-biphenylyl)amine supplier The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). N,N-Bis(4′-diphenylamino-4-biphenylyl)amine vendor As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. N,N-Bis(4′-diphenylamino-4-biphenylyl)amine factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.